retatrutide fda approval status 2024 🎥 Eli Lilly’s next generation weight-loss drug, Retatrutide, could hit the shelves soon. Though the treatment has yet to attain approval, demand is already so heavy that consumers are going to the Eli Lilly Files Suit Challenging

Lilly said the once-daily pill, Foundayo, will start shipping from direct-to-consumer platform LillyDirect on Monday and will be available at pharmacies and on telehealth platforms "shortly after." People with insurance coverage could pay $25 a month with a coupon from Lilly, while people paying out of pocket could pay between $149 and $349, depending on the dose

That's our job as responsible scientists. It also remains unknown whether there will be any new side effects that pop up if people remain on these drugs for 30, 40, or 50-plus years

Clinical outcomes of Tirzepatide or GLP-1 receptor agonists in individuals with type 2 diabetes

2021;320(4):G61726

This enzyme breaks stored triglycerides into free fatty acids and glycerol, releasing them into the bloodstream for oxidation